Want to join the conversation?
$CBG 2Q15 Call: At the midpoint of 2015, CBRE is on course for another year of very strong financial performance. We are intensely focused on executing strategy to sustain long-term secular growth & further extend position as the industry leader. During the first half of 2015, we completed 3 infill acquisitions that enhanced our service offering.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.